I'm in the spikes of poetry and far away
Release time:
2020-08-14
I joined the big family of Peak Health and became an employee of the Plant Extraction Division in December of 2014
■ Peak Health
. More than half a year later, because of the working experience of the office, I was transferred to the administration and personnel department as the administrative director on the recommendation of Zhou Huijuan, the financial director, and started the office work again. Although I have worked in the office for many years, there are great differences between institutions and enterprises in terms of workflow and content. When I arrived at my new position, I asked myself to familiarize myself with the process as quickly as possible so that I could really take over the administrative work as soon as possible. At the same time, the company also asked me to be responsible for the declaration of government projects. This work is highly professional, time-sensitive, and has nothing to do with administrative personnel, which makes me even more uncertain. To this end, I started from scratch, asked teachers from relevant government departments humbly, carefully analyzed and learned from relevant materials, and repeatedly revised the application materials. Now, over the past three years or so, the project subsidy that I have applied for and approved has actually reached more than
million yuan, and I still feel a sense of accomplishment. 2016
10 , the administration and personnel department was reduced from three to two, and the company needed a large number of personnel to fill sales, workshop management and research and development positions due to business adjustment, and the responsibility of personnel recruitment fell on my shoulders. For more than a year, I have been running non-stop in colleges and universities and the talent market, participating in various job fairs, patiently introducing the peak culture and spirit, strength and vision to everyone who comes to consult, telling them my own personal work experience and feelings, and recommending suitable positions according to their majors, academic qualifications and specialties. In my WeChat circle of friends, most of them are "XX job fair" messages, so the messages from relatives and friends are also very similar: "You are so busy." "It's so hard." "Recruiting again?" Yes, I am busy and tired, but I am full. People who have done administrative and personnel work all know that this job is very busy, and when I look back after it is finished, it is mostly trivial, messy and tedious. However, I always have a grateful heart, work hard, work hard, and strive to find and embody my own value in ordinary work.
At the peak, in addition to work, I also got an unexpected harvest. "Peak News" is a window for us to show the image of the peak and the talents of our employees. The administrative departments of various enterprises are also an important channel for information exchange within the group. Therefore, I will write some news reports and contribute articles from time to time, which has played a publicity and display effect for the health company in the whole group. I had a lot of communication with the editorial department. I accidentally talked about that I had studied traditional Chinese painting when I was a student. At that time, the supplement of Jianfeng Bao happened to have a column of "employee column", which recommended an employee author for four consecutive periods every two months. Editor-in-chief Fu enthusiastically asked me for a draft and agreed on two traditional Chinese paintings with similar themes in each issue, accompanied by corresponding essays. At that time, I had not taken a paintbrush for nearly
years. There was a daughter in the second year of junior high school and a nine-month-old son to take care of. It seemed impossible to complete this "task. However, Lu Xun said that time is like water in a sponge. As long as you are willing to squeeze, there will always be time. During that time, after waiting for the children to sleep every night, I began to create traditional Chinese painting, which was finally completed within the scheduled time, becoming the first employee of Jianfeng Health Company to open a column in Jianfeng newspaper. Through the "peak newspaper", my Chinese painting was selected to participate in the annual national building materials industry calligraphy and painting exhibition, but also fortunate to be included in the seventh and eighth calligraphy and painting exhibition works collection; not long ago, the closing of the first Zhejiang building materials industry calligraphy and painting exhibition also exhibited a piece of my work, to participate in the ninth national building materials industry calligraphy and painting exhibition works have also been sent ...... Once far away for many years, has now become an indispensable part of my life. Work is not only a means of making a living, but also a peak. It provides me with stable work and a broad development platform. It is the decision-making of leaders and the cooperation of teams, which makes me find the motivation and direction of my work. I thank everyone who guides me and encourages me in my work, and thank you for allowing me to continuously gain and improve.
If work is poetry, then painting is far away. At the peak, there are my poems and the distance......
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31